Results 151 to 160 of about 378,540 (249)

Long-term outcome of juvenile dermatomyositis associated with lipodystrophy: experience of a University hospital. [PDF]

An Bras Dermatol
Kapetanović I, Gajić-Veljić M, Bonači-Nikolić B, Nikolić M.   +3 more
europepmc   +1 more source

Juvenile Dermatomyositis

Nishi Nihon Hifuka, 1997
KUBOTA, Yumiko, KOGA, Tetsuya, TOSHITANI, Shoji   +2 more
openaire   +1 more source

Tofacitinib monotherapy as maintenance treatment in juvenile dermatomyositis: a case report. [PDF]

RMD Open
Argüelles Balas D, Barral Mena E, Martín Díaz MÁ, Calvo-Aranda E.   +3 more
europepmc   +1 more source

Juvenile Dermatomyositis with Systemic Capillary Leak Syndrome Complicated by Disseminated Aspergillosis: A Case Report

Granthana Mandal, Prabhas Prasun Giri, Kaushik Maulik, Madiha Zainab, Agnisekhar Saha, Rajiv Sinha   +5 more
openalex   +1 more source

Application of HRCT-based radiomics to predict interstitial lung disease for juvenile dermatomyositis. [PDF]

BMC Pediatr
Liu L, Hu M, Zhou Y, Zheng F, Ma X, Yang L, Xu Y, Teng L, Hu B, Lu M, Xu X.   +10 more
europepmc   +1 more source

Transaminitis as the initial presentation of anti-MDA5 positive juvenile dermatomyositis: A case report

Mirandy Li, Chyna Beck-Taylor, Jacinta E. Cooper   +2 more
openalex   +1 more source

Juvenile dermatomyositis [PDF]

, 2020
openaire   +1 more source

Physical Growth Dynamics of Children With Juvenile Dermatomyositis. [PDF]

Cureus
Soni K, Kaur H, Gupta A, Singh S, Saha SC, Bhalla A.   +5 more
europepmc   +1 more source

Reliability of durometry to assess firmness of calcinosis lesions in Juvenile and adult dermatomyositis

Meghan Corrigan Nelson, Lisa G. Rider, Hanna Hyun Kim, Scott Gillespie, Vy Do, Julie Fuller, Kelly Rouster-Stevens, Adam Schiffenbauer   +7 more
openalex   +2 more sources

Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providers. [PDF]

Rheumatology (Oxford)
Sherman MA, Nicolai R, Datyner EK, Rosina S, Hamilton A, Ardalan K, Bader-Meunier B, Brown AG, Jansen MHA, Kim S, Lang B, Campanilho-Marques R, McCann LJ, Sanner H, Veldkamp SR, Wilkinson MGL, Yi BY, Kim H, Tarvin SE, Papadopoulou C, CARRA JDM Therapeutics Workgroup and the PReS JDM Working Party.   +20 more
europepmc   +1 more source